Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy

The number of blind and low vision persons in the US is projected to increase to 5.68 million by 2020. The eye diseases causing loss of vision are life-long, chronic, and often need protracted presence of therapeutics at the disease site to keep the disease in remission. In addition, multiple pathol...

Descripción completa

Detalles Bibliográficos
Autores principales: Warther, David, Xiao, Ying, Li, Fangting, Wang, Yuqin, Huffman, Kristyn, Freeman, William R., Sailor, Michael, Cheng, Lingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058705/
https://www.ncbi.nlm.nih.gov/pubmed/29996687
http://dx.doi.org/10.1080/10717544.2018.1486474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058705/
https://www.ncbi.nlm.nih.gov/pubmed/29996687
http://dx.doi.org/10.1080/10717544.2018.1486474

Ejemplares similares